Real world patterns of dyslipidemia care before and after a national fee revision in Japan: A nationwide study using a 30 million patient claims database. [PDF]
Yamasaki S, Tokunou T, Horiuchi T.
europepmc +1 more source
ATP Citrate Lyase in Metabolic Disease: Mechanistic Insights and Clinical Potential
ATP citrate lyase (ACLY) is a central metabolic hub that diverts mitochondrial citrate to fuel de novo lipogenesis, cholesterol biosynthesis, and protein acetylation. Given its robust correlation with pathological changes in multiple human diseases, ACLY inhibitors featuring distinct pharmacological strengths have been developed for therapeutic ...
Wenbiao Wang +5 more
wiley +1 more source
Prevalence and risk factor analysis of early-onset dyslipidemia-a cross-sectional study of 3.7 million population. [PDF]
Liu F +9 more
europepmc +1 more source
Bisphenol A and Its Analogs: Toxicity Analysis in Mouse and Rat Liver—A Review
ABSTRACT Bisphenol A (BPA) and its analogs are widely recognized for their use in industry and plastic manufacturing. Consequently, humans and animals are continually exposed to various substances in their daily lives. This review evaluates the hepatic toxicity of BPA and its analogs in mice and rats, with particular emphasis on molecular mechanisms ...
Sevda Bagdatli +5 more
wiley +1 more source
Association of platelet-to-HDL cholesterol ratio with hyperuricemia among Qatari adults: a national primary care study. [PDF]
Dorter M, Eid A, Saad ND.
europepmc +1 more source
Bisphenol M Induces Dose‐Dependent Hepatic Injury and Fibrotic Remodeling in Female Mice
ABSTRACT The safety of bisphenol analogs as alternatives to bisphenol A (BPA) is increasingly concerning. This study investigated the hepatotoxic effects of bisphenol M (BPM), a widely used BPA substitute, in 6‐week‐old female BALB/c mice exposed to 2.5, 5, and 10 mg/kg/day intraperitoneally for 14 days. Hepatic changes were assessed via histopathology,
Muhammed Canik +3 more
wiley +1 more source
Daytime nap and nighttime sleep duration in relation to dyslipidemia among type 2 diabetes patients in eastern China: a cross-sectional study. [PDF]
Chen X, Lu F, Zhang J, He Q, Zhong J.
europepmc +1 more source
The MyμAlbumin device is a high‐precision, real‐time immunoturbidimetric point‐of‐care tool for rapid quantification of urinary albumin, designed to improve early detection of chronic kidney disease (CKD). Clinical validation with 138 patients demonstrated exceptional diagnostic accuracy, achieving a sensitivity of 99.11% and specificity of 98.23 ...
Tullayakorn Plengsuriyakarn +5 more
wiley +1 more source

